Bleomycin and perioperative care: a case report.

Area of Science:

• Oncology
• Pulmonology
• Anesthesiology

Background:

• Bleomycin chemotherapy can cause severe pulmonary toxicity, including pneumonitis and fibrosis.
• Oxygen administration, especially during anesthesia, can exacerbate bleomycin-induced lung injury.
• Managing patients with prior bleomycin toxicity undergoing surgery presents significant anesthetic challenges.

Purpose of the Study:

• To report the successful perioperative management of a patient with documented bleomycin pulmonary toxicity.
• To describe the multidisciplinary approach to minimize pulmonary complications during major surgery in this high-risk patient.
• To emphasize the importance of tailored anesthetic and postoperative care strategies.

Main Methods:

• Comprehensive preoperative assessment and optimization of respiratory function.
• Implementation of chest physiotherapy, inhaled corticosteroids, and bronchodilators.
• Strict intraoperative management including restricted oxygen and fluid administration.
• Vigilant postoperative care to monitor and prevent pulmonary complications.

Main Results:

• The patient successfully underwent an eight-hour retroperitoneal surgery without evidence of further pulmonary insult.
• Perioperative interventions effectively mitigated the risk of exacerbating bleomycin-induced lung injury.
• The described management strategy proved successful in preventing postoperative respiratory complications.

Conclusions:

• Successful surgical outcomes are achievable in patients with bleomycin pulmonary toxicity through meticulous perioperative care.
• A multidisciplinary approach focusing on respiratory support and cautious anesthetic management is crucial.
• This case highlights the importance of individualized patient management to minimize risks associated with bleomycin-related lung damage.